$2,120,000 of NOVO NORDISK INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Obesity, Treat and Reduce Obesity Act, Insulin Pricing/affordability, IRA implementation, supply chain, 340B, Intellectual Property/patent protection, S. 150 - the Affordable Prescriptions for Patients Act, Protect 340B Act, PBM Reform Act, General Compounding Labor-HHS Appropriations Bill, Military Construction, Treat and Reduce Obesity Act, General Compounding, FDA Agricultural Appropriations bill Obesity, Treat and Reduce Obesity Act, IRA implementation, General engagement around Most Favored Nation drug pricing S. 150, Affordable Prescriptions for Patients Act, Patent Protection, General IP Issues, General Compounding International and corporate tax, H.R. 1 One Big Beautiful Bill Discussed potential tariffs."
You can find more data on corporate lobbying on Quiver Quantitative.
NVO Congressional Stock Trading
Members of Congress have traded $NVO stock 12 times in the past 6 months. Of those trades, 9 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $NVO stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 5 times. They made 2 purchases worth up to $30,000 on 10/30, 09/11 and 3 sales worth up to $45,000 on 10/31, 10/30, 08/04.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $80,000 on 10/15, 08/28, 08/19 and 0 sales.
- REPRESENTATIVE SCOTT FRANKLIN has traded it 4 times. They made 4 purchases worth up to $95,000 on 08/04 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
NVO Hedge Fund Activity
We have seen 625 institutional investors add shares of NVO stock to their portfolio, and 805 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JENNISON ASSOCIATES LLC removed 17,659,339 shares (-93.5%) from their portfolio in Q3 2025, for an estimated $979,916,721
- FRANKLIN RESOURCES INC added 13,658,867 shares (+4190.8%) to their portfolio in Q3 2025, for an estimated $757,930,529
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 10,005,216 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $555,189,435
- CLEARBRIDGE INVESTMENTS, LLC removed 7,332,020 shares (-89.2%) from their portfolio in Q3 2025, for an estimated $406,853,789
- SUSTAINABLE GROWTH ADVISERS, LP removed 6,187,063 shares (-99.9%) from their portfolio in Q3 2025, for an estimated $343,320,125
- CAPITAL INTERNATIONAL INVESTORS added 6,092,192 shares (+52.4%) to their portfolio in Q3 2025, for an estimated $338,055,734
- BOSTON PARTNERS added 5,571,017 shares (+inf%) to their portfolio in Q3 2025, for an estimated $309,135,733
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NVO Analyst Ratings
Wall Street analysts have issued reports on $NVO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 11/28/2025
- Jefferies issued a "Underperform" rating on 10/27/2025
- Morgan Stanley issued a "Underweight" rating on 09/29/2025
- Berenberg issued a "Buy" rating on 09/17/2025
- TD Cowen issued a "Buy" rating on 08/19/2025
To track analyst ratings and price targets for NVO, check out Quiver Quantitative's $NVO forecast page.
NVO Price Targets
Multiple analysts have issued price targets for $NVO recently. We have seen 6 analysts offer price targets for $NVO in the last 6 months, with a median target of $62.0.
Here are some recent targets:
- An analyst from CICC set a target price of $73.5 on 01/09/2026
- James Quigley from Goldman Sachs set a target price of $54.0 on 11/28/2025
- Evan David Seigerman from BMO Capital set a target price of $46.0 on 11/25/2025
- Rajesh Kumar from HSBC set a target price of $70.0 on 10/02/2025
- Thibault Boutherin from Morgan Stanley set a target price of $47.0 on 09/29/2025
- Michael Nedelcovych from TD Cowen set a target price of $70.0 on 08/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
